VYGR — Voyager Therapeutics Share News
0.000.00%
Last trade - 00:00- $107.22m
- -$9.12m
- $40.37m
U.S. STOCKS ON THE MOVE-Fastly, pot stocks, Lightspeed
U.S. STOCKS ON THE MOVE-Lululemon Athletica, cruise stocks, Super Micro
U.S. STOCKS ON THE MOVE-Intel, PTC Therapeutics, Senti Bio
Voyager Therapeutics rises after Citigroup starts coverage with 'buy'
U.S. STOCKS ON THE MOVE-WW Grainger, Silo Pharma, Prologis
Voyager Therapeutics rises after Wedbush starts with 'outperform'
Brief: Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
Voyager Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Voyager Therapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview
Voyager Therapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics
U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics
Voyager Therapeutics rises after Leerink starts coverage with 'outperform'
U.S. STOCKS ON THE MOVE-MarketAxess, Perpetua Resources, Sotera Health
U.S. STOCKS ON THE MOVE-Modular Medical, Beazer Homes, oil firms
Voyager climbs on expanded licensing deal with Novartis
Brief: Voyager Enters Into License For Next-Generation Capsid, Bringing Partnered Portfolio Of Tracer-Enabled Gene Therapies To 14
Voyager Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Voyager Therapeutics Inc expected to post a loss of 41 cents a share - Earnings Preview